| A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability F Zalfa, B Eleuteri, KS Dickson, V Mercaldo, S De Rubeis, A di Penta, ... Nature neuroscience 10 (5), 578-587, 2007 | 412 | 2007 |
| Molecular dissection of the events leading to inactivation of the FMR1 gene R Pietrobono, E Tabolacci, F Zalfa, I Zito, A Terracciano, U Moscato, ... Human molecular genetics 14 (2), 267-277, 2005 | 143 | 2005 |
| A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the Attention Deficit Hyperactivity Disorder in Fragile X Syndrome boys G Neri, E Tabolacci, P Chiurazzi Am Jour Med Genet-Part A, 803-812, 2008 | 131* | 2008 |
| A double‐blind, parallel, multicenter comparison of L‐acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys MG Torrioli, S Vernacotola, L Peruzzi, E Tabolacci, M Mila, R Militerni, ... American Journal of Medical Genetics Part A 146 (7), 803-812, 2008 | 128 | 2008 |
| Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5‐azadeoxycytidine R Pietrobono, MG Pomponi, E Tabolacci, B Oostra, P Chiurazzi, G Neri Nucleic acids research 30 (14), 3278-3285, 2002 | 126 | 2002 |
| Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations E Tabolacci, U Moscato, F Zalfa, C Bagni, P Chiurazzi, G Neri European journal of human genetics 16 (12), 1487-1498, 2008 | 111 | 2008 |
| Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments E Tabolacci, R Pietrobono, U Moscato, BA Oostra, P Chiurazzi, G Neri European journal of human genetics 13 (5), 641-648, 2005 | 111 | 2005 |
| Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys MG Torrioli, S Vernacotola, C Setini, F Bevilacqua, D Martinelli, M Snape, ... American Journal of Medical Genetics Part A 152 (6), 1420-1427, 2010 | 93 | 2010 |
| The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception N Cappoli, E Tabolacci, P Aceto, CD Russo Journal of Neuroimmunology 349, 577406, 2020 | 90 | 2020 |
| A truncating mutation in the IL1RAPL1 gene is responsible for X‐linked mental retardation in the MRX21 family E Tabolacci, MG Pomponi, R Pietrobono, A Terracciano, P Chiurazzi, ... American Journal of Medical Genetics Part A 140 (5), 482-487, 2006 | 62 | 2006 |
| Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1 P Casalbore, M Budoni, L Ricci-Vitiani, C Cenciarelli, G Petrucci, ... PLoS One 4 (2), e4434, 2009 | 56 | 2009 |
| MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty‐nine novel mutations identified R Ferrentino, MT Bassi, D Chitayat, E Tabolacci, G Meroni Human mutation 28 (2), 206-207, 2007 | 53 | 2007 |
| X-linked mental retardation (XLMR): from clinical conditions to cloned genes P Chiurazzi, E Tabolacci, G Neri Critical reviews in clinical laboratory sciences 41 (2), 117-158, 2004 | 53 | 2004 |
| Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation E Tabolacci, I De Pascalis, M Accadia, A Terracciano, U Moscato, ... Pharmacogenetics and genomics 18 (8), 738-741, 2008 | 51 | 2008 |
| Transcriptional reactivation of the FMR1 gene. A possible approach to the treatment of the fragile X syndrome E Tabolacci, F Palumbo, V Nobile, G Neri Genes 7 (8), 49, 2016 | 46 | 2016 |
| Epigenetics, fragile X syndrome and transcriptional therapy E Tabolacci, P Chiurazzi American journal of medical genetics Part A 161 (11), 2797-2808, 2013 | 44 | 2013 |
| Role of CTCF Protein in Regulating FMR1 Locus Transcription S Lanni, M Goracci, L Borrelli, G Mancano, P Chiurazzi, U Moscato, ... PLoS genetics 9 (7), e1003601, 2013 | 44 | 2013 |
| The FRAXopathies: Definition, overview, and update F Pirozzi, E Tabolacci, G Neri American Journal of Medical Genetics Part A 155 (8), 1803-1816, 2011 | 44 | 2011 |
| Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients A Modoni, MF Contarino, AR Bentivoglio, E Tabolacci, M Santoro, ... Movement disorders: official journal of the Movement Disorder Society 22 (3 …, 2007 | 42 | 2007 |
| Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells E Tabolacci, G Mancano, S Lanni, F Palumbo, M Goracci, F Ferrè, ... Epigenetics & chromatin 9 (1), 1-15, 2016 | 32 | 2016 |
